Literature DB >> 22252445

Minimal polyketide pathway expression in an actinorhodin cluster-deleted and regulation-stimulated Streptomyces coelicolor.

Han-Na Lee1, Hye-Jin Kim, Pil Kim, Heung-Shick Lee, Eung-Soo Kim.   

Abstract

Along with traditional random mutagenesis-driven strain improvement, cloning and heterologous expression of Streptomyces secondary metabolite gene clusters have become an attractive complementary approach to increase its production titer, of which regulation is typically under tight control via complex multiple regulatory networks present in a metabolite low-producing wild-type strain. In this study, we generated a polyketide non-producing strain by deleting the entire actinorhodin cluster from the chromosome of a previously generated S. coelicolor mutant strain, which was shown to stimulate actinorhodin biosynthesis through deletion of two antibiotic downregulators as well as a polyketide precursor flux downregulator (Kim et al. in Appl Environ Microbiol 77:1872-1877, 2011). Using this engineered S. coelicolor mutant strain as a surrogate host, a model minimal polyketide pathway for aloesaponarin II, an actinorhodin shunt product, was cloned in a high-copy conjugative plasmid, followed by functional pathway expression and quantitative metabolite analysis. Aloesaponarin II production was detected only in the presence of a pathway-specific regulatory gene, actII-ORF4, and its production level was the highest in the actinorhodin cluster-deleted and downregulator-deleted mutant strain, implying that this engineered polyketide pathway-free and regulation-optimized S. coelicolor mutant strain could be used as a general surrogate host for efficient expression of indigenous or foreign polyketide pathways derived from diverse actinomycetes in nature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252445     DOI: 10.1007/s10295-011-1083-8

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  22 in total

Review 1.  Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.

Authors:  Narayan Prasad Niraula; Seon-Hye Kim; Jae Kyung Sohng; Eung-Soo Kim
Journal:  Appl Microbiol Biotechnol       Date:  2010-05-28       Impact factor: 4.813

2.  Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species.

Authors:  Hiroyasu Onaka; Yukiko Mori; Yasuhiro Igarashi; Tamotsu Furumai
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

Review 3.  Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering.

Authors:  Carlos Olano; Felipe Lombó; Carmen Méndez; José A Salas
Journal:  Metab Eng       Date:  2008-07-15       Impact factor: 9.783

4.  Transcriptome analysis of an antibiotic downregulator mutant and synergistic Actinorhodin stimulation via disruption of a precursor flux regulator in Streptomyces coelicolor.

Authors:  Seon-Hye Kim; Han-Na Lee; Hye-Jin Kim; Eung-Soo Kim
Journal:  Appl Environ Microbiol       Date:  2011-01-07       Impact factor: 4.792

5.  Heterologous expression of human interleukin-6 in Streptomyces lividans TK24 using novel secretory expression vectors.

Authors:  Yuanjun Zhu; Lifei Wang; Yu Du; Songmei Wang; Tengfei Yu; Bin Hong
Journal:  Biotechnol Lett       Date:  2010-10-08       Impact factor: 2.461

6.  Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate.

Authors:  Jennifer N Andexer; Steven G Kendrew; Mohammad Nur-e-Alam; Orestis Lazos; Teresa A Foster; Anna-Sophie Zimmermann; Tony D Warneck; Dipen Suthar; Nigel J Coates; Frank E Koehn; Jerauld S Skotnicki; Guy T Carter; Matthew A Gregory; Christine J Martin; Steven J Moss; Peter F Leadlay; Barrie Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

7.  Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.

Authors:  M Bierman; R Logan; K O'Brien; E T Seno; R N Rao; B E Schoner
Journal:  Gene       Date:  1992-07-01       Impact factor: 3.688

8.  Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism.

Authors:  Mamoru Komatsu; Takuma Uchiyama; Satoshi Omura; David E Cane; Haruo Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

9.  Genetically modified bacterial strains and novel bacterial artificial chromosome shuttle vectors for constructing environmental libraries and detecting heterologous natural products in multiple expression hosts.

Authors:  Asuncion Martinez; Steven J Kolvek; Choi Lai Tiong Yip; Joern Hopke; Kara A Brown; Ian A MacNeil; Marcia S Osburne
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

10.  Heterologous expression of an engineered biosynthetic pathway: functional dissection of type II polyketide synthase components in Streptomyces species.

Authors:  E S Kim; K D Cramer; A L Shreve; D H Sherman
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

View more
  3 in total

1.  Biomass-derived molecules modulate the behavior of Streptomyces coelicolor for antibiotic production.

Authors:  Shashi Kant Bhatia; Bo-Rahm Lee; Ganesan Sathiyanarayanan; Hun Seok Song; Junyoung Kim; Jong-Min Jeon; Jeong-Jun Yoon; Jungoh Ahn; Kyungmoon Park; Yung-Hun Yang
Journal:  3 Biotech       Date:  2016-10-15       Impact factor: 2.406

2.  Identification and biotechnological application of novel regulatory genes involved in Streptomyces polyketide overproduction through reverse engineering strategy.

Authors:  Ji-Hye Nah; Hye-Jin Kim; Han-Na Lee; Mi-Jin Lee; Si-Sun Choi; Eung-Soo Kim
Journal:  Biomed Res Int       Date:  2013-03-04       Impact factor: 3.411

3.  Rational engineering of Streptomyces albus J1074 for the overexpression of secondary metabolite gene clusters.

Authors:  Dimitris Kallifidas; Guangde Jiang; Yousong Ding; Hendrik Luesch
Journal:  Microb Cell Fact       Date:  2018-02-17       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.